为了合理化儿童和成人使用抑制酸性药物的多学科共识:CONFOR
Ram Y Prabhoo1, Uday A Pai2, Arun Wadhwa3
1Department of Orthopedics, Mukund Hospital, Mumbai, Maharashtra, India.
Euroasian journal of hepato-gastroenterology
|July 18, 2024
概括
这项研究提供了关于合理使用抑制酸的专家共识,为适当的处方和减期的质子抑制剂 (PPI) 提供了指导方针,以提高患者的安全性和降低成本.
科学领域:
- 胃肠病学 胃肠病学
- 药理学 药理学是指药理学的学科.
- 基于证据的医学 基于证据的医学
背景情况:
- 酸抑制疗法 (AST) 广泛用于酸性胃肠疾病.
- 质子抑制剂 (PPI) 和组胺类型2受体对抗剂 (H2RAs) 是常见的AST.
- 人们对不适当的PPI使用和对儿童和成人的不良影响存在担忧.
研究的目的:
- 建立最佳实践共识声明,以合理化AST使用.
- 解决有关过度使用PPE和相关不良影响的担忧.
- 开发一个PPI解写算法.
主要方法:
- 一个三步修改的Delphi投票过程.
- 一个由13名卫生专业人员组成的多学科专家小组.
- 综合审查科学文献和临床专业知识.
主要成果:
- 关于酸性抑制剂的一般使用和安全性的21个共识声明.
- 一个PPI描述算法是协同开发的.
- 基于证据的建议,以合理使用AST.
结论:
- 该共识为初级保健从业者提供了指导.
- 旨在改善患者的治疗结果,并尽量减少医疗保健成本.
- 通过减少不适当的使用来提高患者的安全性.
相关概念视频
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
365
Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
365
Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids
339
In the complex environment of the gastric lumen, excessive acid secretion can lead to the formation or worsening of ulcers within the delicate mucosal layer. Antacids, such as sodium bicarbonate and calcium carbonate, provide relief by neutralizing this acid, transforming it into harmless salt and water. This neutralization process raises the gastric pH from a highly acidic level of 1 to a more basic 3-4, reducing the acidity within the stomach.
However, this neutralization reaction between...
However, this neutralization reaction between...
339
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
415
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
415
Peptic Ulcer Disease IV: Management
83
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
83
Gastroesophageal Reflux Disease II: Clinical Features and Management
68
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
68
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
364
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
364


